Atlas Trials

A Pharmacokinetic Dose Proportionality Study of Canagliflozin in Healthy Volunteers

Clinical trial NCT01340677 · COMPLETED

Trial details

NCT number
NCT01340677
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2011-05-01
Primary completion
2011-08-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.